drugset / Trial / NCT00308711

Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor

NCT00308711

Phase 3 Completed 1308 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the misoprostol vaginal insert (50 mcg and 100 mcg) can safely and effectively speed time to vaginal delivery compared to Cervidil (R) in women who need to have cervical ripneing and induction of labor.

Timeline

Start
2006-04
Primary completion
2007-08
Completion
2007-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 10 mg Other
Subject Misoprostol Other / unclassified 50 ug Other
Subject Misoprostol Other / unclassified 100 ug Other

Indications